Literature DB >> 20170662

Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide.

Kana Shimada1, Taka-aki Okabe, Yu Mikami, Miki Hattori, Masatoshi Fujita, Chiharu Kishimoto.   

Abstract

We systematically investigated serial efficacy of granulocyte colony-stimulating factor (G-CSF) therapy upon experimental autoimmune myocarditis (EAM) in rats treated with and without the inhibition of nitric oxide (NO) with the analyses of tissue regeneration. G-CSF could mobilize multipotent progenitor cells of bone marrow into the peripheral blood and may improve ventricular function. A rat model of porcine myosin-induced EAM was used. After the immunization of myosin, G-CSF (10 microg/kg/day) or saline was injected intraperitoneally on days 0-21 in experiment 1 and on days 21-42 in experiment 2. Additional myosin-immunized rats were orally given 25 mg/kg/day of N(G)-nitro-L-arginine methylester (L-NAME), an inhibitor of nitric oxide synthase (NOS), in each experiment (each group; n=8-21). Serum cytokines and peripheral blood cell counts were measured in each group. In experiment 1, G-CSF treatment aggravated cardiac pathology associated with increased macrophage inflammatory protein-2 (MIP-2) and interleukin-6 (IL-6) levels and enhanced superoxide production. In experiment 2, G-CSF treatment reduced the severity of myocarditis with increased capillary density and improved left ventricular ejection fraction. In the rats with EAM treated with G-CSF associated with oral L-NAME treatment in experiment 2, the severity of myocarditis was not reduced. Myocardial c-kit(+) cells were demonstrated only in G-CSF-treated group in experiment 2 but not in other groups. G-CSF has differential effects on EAM in rats associated with the modulation of cytokine network. The overwhelming superoxide production by G-CSF administration in the acute stage may worsen the disease. G-CSF therapy improved cardiac function via NO system in a rat model of myocarditis in the chronic stage, but not in the acute stage, possibly through the myocardial regeneration and acceleration of healing process. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170662     DOI: 10.1016/j.yjmcc.2010.02.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Authors:  Shouxin Zhang; Xiaoyan Liu; Chengming Sun; Jun Yang; Lihong Wang; Jie Liu; Lei Gong; Yanyan Jing
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

Review 2.  Advances in monoclonal antibody application in myocarditis.

Authors:  Li-na Han; Shuang He; Yu-tang Wang; Li-ming Yang; Si-yu Liu; Ting Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

3.  The effect of experimental streptococcus infection in myocarditis on some biochemical and inflammatory markers in albino rats.

Authors:  S R Kholoud; M K A Iman; E H Rasha; S S A Soha
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

4.  Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Eveliina Pollari; Ekaterina Savchenko; Merja Jaronen; Katja Kanninen; Tarja Malm; Sara Wojciechowski; Toni Ahtoniemi; Gundars Goldsteins; Raisa Giniatullina; Rashid Giniatullin; Jari Koistinaho; Johanna Magga
Journal:  J Neuroinflammation       Date:  2011-06-28       Impact factor: 8.322

5.  Granulocyte colony-stimulating factor attenuates monocrotaline-induced pulmonary hypertension by upregulating endothelial progenitor cells via the nitric oxide system.

Authors:  Jun-Feng Liu; Zhong-Dong DU; Zhi Chen; Zhong-Chao Han; Zhi-Xu He
Journal:  Exp Ther Med       Date:  2013-10-07       Impact factor: 2.447

6.  Whole bone marrow cell culture: A convenient protocol for the in vitro expansion of endothelial progenitor cells.

Authors:  Jun-Feng Liu; Zhong-Dong DU; Zhi Chen; Zhi-Xu He
Journal:  Exp Ther Med       Date:  2014-07-04       Impact factor: 2.447

7.  Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization.

Authors:  Honghui Yang; Yan Chen; Chuanyu Gao
Journal:  Oncotarget       Date:  2017-08-10

8.  Baicalein Protects Rats with Diabetic Cardiomyopathy Against Oxidative Stress and Inflammation Injury via Phosphatidylinositol 3-Kinase (PI3K)/AKT Pathway.

Authors:  Lin Ma; Xiang Peng Li; Heng Sheng Ji; Yue Fen Liu; En Ze Li
Journal:  Med Sci Monit       Date:  2018-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.